help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, H.
Right arrow Articles by Mizunuma, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, H.
Right arrow Articles by Mizunuma, H.
Endocrinology Vol. 142, No. 11 4930-4936
Copyright © 2001 by The Endocrine Society


ARTICLES

Effect of Adrenal and Ovarian Androgens on Type 4 Follicles Unresponsive to FSH in Immature Mice

Hua Wang, Kazumichi Andoh, Haruo Hagiwara, Liu Xiaowei, Nobumasa Kikuchi, Yumiko Abe, Kiyohiko Yamada, Riasat Fatima and Hideki Mizunuma

Department of Obstetrics and Gynecology (H.W., K.A., L.X., N.K., Y.A., K.Y., R.F.), and First Department of Anatomy (H.H.), Gunma University School of Medicine, Gunma 371-8511; and Department of Obstetrics and Gynecology, Hirosaki University School of Medicine (H.M.), Hirosaki 036-8562, Japan

Address all correspondence and requests for reprints to: Hideki Mizunuma, M.D., Department of Obstetrics and Gynecology, Hirosaki University School of Medicine, 5 Zaifu-cho, Hirosaki, Aomori, 036-8562 Japan. E-mail: mizunuma{at}cc.hirosaki-u.ac.jp


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The present study investigates the physiological significance of dehydroepiandrosterone, dehydroepiandrosterone sulfate, T, androstenedione ({Delta}4), dihydrotestosterone (DHT), estrone (E1), and E2 on recombinant human FSH- (rhFSH) resistant type 4 follicles obtained from immature mice. Type 4 follicles of a diameter of 100–120 µm with one or two granulosa cell layers around the oocyte and an intact basal lamina with theca cells were isolated from the ovaries of 11-d-old BDF-1 mice and cultured with medium alone (control) or with dehydroepiandrosterone, dehydroepiandrosterone sulfate, T, {Delta}4, DHT, E1, or E2 at concentrations ranging from 1 x 10-11 to 1 x 10-7 M for 4 d. We examined the mean diameters of type 4 follicles, levels of immunoreactive (IR)-inhibin, and E2 and progesterone in the culture media on day 4. In addition, we evaluated follicular cell proliferation by immunofluorescence staining with 5-bromo-2'-deoxyuridine. All tested androgens significantly increased the diameter of type 4 follicles in a dose-dependent manner without the production of IR-inhibin and E2. The nuclei of granulosa cells in type 4 follicles cultured with all tested androgens exhibited intense 5-bromo-2'-deoxyuridine-positive staining, compared with those of controls. In contrast, neither E1 nor E2 had any stimulatory effects. The stimulatory effects of T, {Delta}4, or DHT were inhibited by an AR antagonist in a dose-related fashion but not by an aromatase inhibitor. Furthermore, all tested androgens had a synergistic effect with rhFSH on follicular growth and the production of IR-inhibin and E2. These results demonstrated that neither adrenal nor ovarian androgens are arteriogenic but that they stimulate type 4 follicles unresponsive to rhFSH and augment the responsiveness of these follicles to rhFSH.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
BECAUSE A SINGLE injection of T reduces ovarian weight and increases the number of atretic follicles in hypophysectomized E-treated immature rats (1, 2) and an injection of the nonaromatizable androgen, 5{alpha}-dihydrotestosterone (DHT) to normal cycling mice reduces the number of normal large follicles by 50% (3), ovarian androgens have long been implicated as an inhibitor of follicular development (4, 5, 6). Recent in vitro studies, however, have shown that T and DHT stimulate the production of progesterone by granulosa cells from hypophysectomized E-treated immature rats (7, 8, 9) and that ovarian androgens enhance the cyclic AMP production (10) as well as the aromatase activity (11, 12) of granulosa cells from normal and E-primed immature rats. In addition, ovarian androgens were found to stimulate the growth of small preantral mouse follicles cultured in vitro (13, 14) and T and DHT to increase the number of follicles as well as theca and granulosa cell proliferation in normal cycling rhesus monkeys (15). These results suggest that ovarian androgens have a stage-specific action on follicular development and can elicit a stimulatory action on follicular growth at the preantral stage. However, whether adrenal androgens have such effects on preantral follicular growth remains unknown. The fact that congenital adrenal hyperplasia causes ovarian dysfunction and premature adrenarche promotes the onset of puberty in women raises the notion that adrenal androgens are involved in ovarian function (16).

Very early follicular growth is gonadotropin independent (17), and the involvement of intra- and extraovarian factors such as activin or GH has been thought important in regulating the first step of folliculogenesis. In immature mice, intra- and extraovarian factors may stimulate small preantral follicles at a level at which they acquire responsiveness to FSH (18, 19). Studies of androgen-resistant testicular feminization mouse (Tfm) female mice have shown impaired reproductive performance, such as premature luteinization and progressive decrease in primordial follicles followed by premature cessation of reproduction (20, 21), although to the best of our knowledge, whether these animals have delayed puberty or a normal response to FSH remains to be clarified. Because ovaries have ARs at birth (22), understanding the role of androgens on follicular growth at very early stages is important for understanding the pathophysiology of prepubertal follicular growth. The present study investigates the physiological role of gonadal and adrenal androgens and estrone (E1) and E2 on follicular growth of immature mouse type 4 follicles that remain unresponsive to FSH.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Chemicals
We purchased 5-androsten-3ß-ol-17-one (DHEA), 5-androsten-3ß-ol-17-one sulfate (DHEAS), 4-androsten-17ß-ol-3-one (T), 4-androsten-3,17-dione ({Delta}4), 5{alpha}-dihydrotestosterone (DHT), 1,3,5(10)-estratriene-3-ol-17-one (E1), and 1,3,5(10)-estratriene-3,17ß-diol (E2) from Sigma (St. Louis, MO). Recombinant human FSH (rhFSH) (lot no. 19505064) was supplied by Organon Co. (Oss, The Netherlands). The AR antagonist, OH-Flutamide, and the aromatase inhibitor, Fadrozole hydrochloride hydrate, were also supplied by Nippon Kayaku Co. (Tokyo, Japan) and Novartis Pharma Co. (Tokyo, Japan). All other chemicals were of analytical grade or of the highest quality commercially available.

Animals
BDF1 hybrid female lactating mice with 7-d-old female pups were purchased from Japan Charles River Laboratories, Inc. (Tokyo, Japan) and housed in a temperature- (24–26 C) and light-controlled room with a 14-h light/10-h dark photoperiod in accordance with the principles of the Animal Care and Experimentation Committee, Gunma University, Showa Campus. The maternal mice were given food and water ad libitum, and the pups were nursed for 4 d. Eleven-day-old immature mice were killed by cervical dislocation.

Follicle isolation and culture
Follicles were mechanically isolated from the ovaries of 11-d-old immature female mice as described (18, 23). Briefly, ovaries were aseptically removed and placed in 15-mm Falcon plastic Petri dishes (FALCON 3037, Becton Dickinson and Co., Rutherford, NJ) containing DMEM (Life Technologies, Inc., Tokyo, Japan) at room temperature. After removing the surrounding tissue, the ovaries were microdissected using two 27-gauge needles attached to 1-ml syringes under a stereomicroscope (Olympus Corp., Tokyo, Japan), and approximately 60 preantral follicles were isolated from each ovary. We cultured type 4 follicles of a diameter of 100–120 µm according to the classification of Pedersen and Peters (24) in a humidified chamber with 5% CO2 in air at 37 C. Type 4 follicles consisted of one to two layers of granulosa cells around the oocyte and an intact basal lamina with theca cells. Histological examination revealed that 86.9% of the sections of these type 4 follicles had at least one thecal cell. This agrees with previous findings that type 4 follicles have 84.5 ± 12.8 granulosa cells per section (18).

Ten type 4 follicles were transferred into 30-mm plastic Falcon Petri dishes containing 1 ml serum-free DMEM supplemented with 6.25 µg/ml of insulin, 6.25 µg/ml of transferrin, 6.25 ng/ml of selenious acid, 5.35 µg/ml of linoleic acid, 0.15% BSA, 15 mM HEPES, 45 µg/ml of penicillin G, 350 µg/ml of streptomycin, and 1.75 µg/ml of Amphotericin before being cultured in a humidified chamber with 5% CO2 in air at 37 C. Type 4 follicles were cultured with medium alone (control) or with DHEA, DHEAS, T, {Delta}4, or DHT at concentrations of 1 x 10-11 to 1 x 10-7 M, and E1 or E2 at concentrations of 1 x 10-11 to 1 x 10-7 M for 4 d without media changes. Next, to ascertain the direct effect of androgens, type 4 follicles were cultured in the presence of T, {Delta}4, or DHT at concentrations of 1 x 10-7 M in combination with an AR antagonist or an aromatization inhibitor at concentrations of 1 x 10-11 to 1 x 10-5 M. Moreover, to clarify the effect of combined rhFSH and androgens, type 4 follicles were cultured with rhFSH at concentrations of 0.1–100 mIU/ml in the presence of 1 x 10-7 M DHEA, DHEAS, T, {Delta}4, or DHT at for 4 d. Each experiment was repeated at least three to five times. Less than 10% of follicles remarkably degraded during 4 d of culture, and these were removed from the medium.

Measurement of follicular diameter and hormone assay
The mean diameter of two-dimensional maximal and minimal lengths in each follicle was measured daily using an inverted microscope (IMT-2, Olympus Corp.). To determine the levels of immunoreactive (IR)-inhibin, E2, and progesterone, the culture medium was collected on day 4 and stored at –20 C. All samples were assayed in duplicate by RIA. IR-inhibin concentrations were measured by double-antibody RIA using rabbit antiserum against bovine follicular fluid inhibin as described (25). E2 levels were determined using an anti-E2 antiserum supplied by Dr. W. F. Crowley, Jr. (26) and estradiol-6-(O-carboxymethyl) oximino-(2-[125I]iodohistamine) (Amersham Pharmacia Biotech, Buckinghamshire, Little Chalfont, UK). The concentrations of progesterone were also measured by double-antibody RIA using a specific rabbit antiserum as described (27). Progesterone-11{alpha}-hemisuccinate-(2-[125I]iodohistamine) was also purchased from Amersham Pharmacia Biotech. The sensitivity levels of the assays for IR-inhibin, E2, and progesterone were 0.04 ng/ml, 1.00 pg/ml, and 0.01 ng/ml, respectively. The intra- and interassay coefficients of variation for IR-inhibin and E2 were 3.2%, and 4.0% and 2.7% and 2.8%, respectively.

Assays of cell proliferation in follicles
Follicular cell proliferation in type 4 follicles cultured with DHEA, DHEAS, T, {Delta}4, or DHT was evaluated by immunofluorescence staining with 5-bromo-2'-deoxyuridine (BrdU) using a cell proliferation kit (Amersham Pharmacia Biotech). Type 4 follicles were cultured with 1 x 10-7 M DHEA, DHEAS, T, {Delta}4, or DHT for 4 d and with 1 x 10-5 M BrdU to label proliferative cells for 60 min in a humidified chamber under 5% CO2 in air at 37 C on day 4. After BrdU labeling, cultured follicles were transferred to poly-L-lysine–coated slide glasses, fixed in 3% paraformaldehyde in 0.1 M PBS (pH 7.4) for 30 min at room temperature, solubilized with 1% Triton X-100 in PBS for 10 min, washed in PBS, and incubated in 2% gelatin in PBS for 15 min at 37 C. The follicles were then incubated with sufficient reconstituted nuclease/anti-BrdU in a wet chamber for 120 min at 37 C, washed six times in 0.1% BSA/PBS, and further incubated with FITC-labeled antimouse IgG (Cappel/ICN, Aurora, Ohio) diluted to 1:100 by 1% BSA/PBS for 60 min at 37 C. Nuclei were stained with TOPRO-3 iodide (Molecular Probes, Inc., Eugene, OR) at a 1: 800 dilution. After six washes in 0.1% BSA/PBS, the follicles were mounted as described (28) and examined under a fluorescence microscope (Axioplan, Carl Zeiss, Jena, Germany) and/or a confocal laser scanning microscope (MRC-1024ES, Bio-Rad Laboratories, Inc. Hemel Hempstead, UK). Negative control sections were processed without the labeling reagent (10-5 M BrdU) or reconstituted nuclease/anti-BrdU. The BrdU index was calculated by dividing the number of BrdU-positive cells by the number of BrdU-positive and TOPRO-3–positive cells.

Statistics
Results are presented as means ± SEM. One-way ANOVA followed by Scheffé’s multiple comparison was performed to determine statistical differences among groups. A value of P < 0.05 was considered statistically significant.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Figure 1Go shows changes in the diameter of type 4 follicles cultured with DHEA, DHEAS, T, {Delta}4, DHT, E1, or E2 at the indicated concentrations for 4 d. The diameter of type 4 follicles increased in a significant dose-dependent manner after stimulation by DHEA, DHEAS, T, {Delta}4, and DHT but not by E1 or E2. These findings suggested that the stimulatory effect of androgens was direct and not a consequence of being converted to E. The minimum effective dose of each androgen was 1 x 10-10 M, and potency did not significantly differ among the tested androgens. Although all tested androgens increased follicular diameter, IR-inhibin secretion was not significantly increased (data not shown). Androgen administration tended to increase E2 secretion, but the difference was not statistically significant, suggesting that the major role of androgens in type 4 follicles is to cause morphological change rather than functional differentiation.



View larger version (30K):
[in this window]
[in a new window]
 
Figure 1. Dose-related changes in diameter of type 4 follicles cultured for 4 d in the presence of DHEA, DHEAS, T, {Delta}4, DHT, E1, or E2 at concentrations of 1 x 10-11 to 1 x 10-7 M. CON, Control. Data are presented as means ± SEM. Parentheses represent numbers of follicles. *, P < 0.05, **, P < 0.01, ***, P < 0.0001 vs. control.

 
Figure 2Go shows the morphological changes of type 4 follicles cultured for 4 d with medium alone (control) and medium containing DHEA, DHEAS, T, {Delta}4, or DHT at a concentration of 1 x 10-7 M (Fig. 2Go, A–F). The diameter of follicles cultured in the presence of each of the androgens (Fig. 2Go, B–F) increased remarkably, compared with that of the control (Fig. 2AGo). Figure 2Go, A'–F' and Fig. 2Go, A''–F'' show BrdU incorporation into granulosa cells. The incorporation of BrdU by follicles cultured in medium containing an androgen significantly increased (Fig. 2Go, B'–F'), as did the number of cells (Fig. 2B'–F'). These findings indicate that androgens stimulate the proliferation of granulosa cells of type 4 follicles.



View larger version (53K):
[in this window]
[in a new window]
 
Figure 2. Phase contact images of type 4 follicles cultured with medium alone (control), 1 x 10-7 M DHEA, DHEAS, {Delta}4, T, or DHT for 4 d. Photographs A'–F' represent BrdU-labeled nuclei and photographs A''–F'' represent double immunofluorescence images with TOPRO-3 (blue) and BrdU (green). (Magnification, x400). BrdU index was calculated by dividing the number of BrdU-positive cells by that of BrdU-positive and TOPRO-3-positive cells.

 
Figure 3Go shows the effects of an AR antagonist (OH-Flutamide) and aromatase inhibitor on follicular diameter of type 4 follicles cultured with 1 x 10-7 M ovarian or adrenal androgens. Although the AR antagonist decreased the diameter of type 4 follicles stimulated by ovarian and adrenal androgens in a dose-related manner, an aromatase inhibitor did not, suggesting that the stimulatory effect of androgens on follicular growth is a direct action.



View larger version (44K):
[in this window]
[in a new window]
 
Figure 3. Effect of AR antagonist on follicular diameter of type 4 follicles stimulated by 1 x 10-7 M DHEA (A), DHEAS (B), T (C), {Delta}4 (D), or DHT (E). AR antagonist at concentrations of 1 x 10-11 to 10-5 M was added on day 0. F and G show effects of aromatase inhibitor on diameter of type 4 follicles stimulated by 1 x 10-7 M T (F) and {Delta}4 (G). Aromatase inhibitor at concentrations of 1 x 10-11 to 1 x 10-5 M was added on day 0. CON, Control. Data are presented as means ± SEM. Parentheses represent numbers of follicles. *, P < 0.05, ***, P < 0.0001 vs. of T 10-7 M, {Delta}4 10-7 M, or DHT 10-7 M. Positive control for aromatase inhibitor (H).

 
Figure 4Go shows the effect of rhFSH on the growth of type 4 follicles cultured for 4 d in the presence of 1 x 10-7 M androgens. Recombinant human FSH alone did not cause any significant change in follicular diameter. However, rhFSH caused a significant and dose-related increase in follicular diameter in conjunction with androgens at a dose of 1 x 10-7 M. Figure 5Go shows IR-inhibin and E2 concentrations in the culture medium. The increase in follicular diameter was accompanied by an increase in IR-inhibin and E2 secretion, suggesting that FSH induced the differentiation of granulosa cells. Although the androgens did not evoke significantly different levels of IR-inhibin secretion, their effects on E2 secretion was significantly different. Among all of the tested androgens, the nonaromatizable androgen DHT was the least potent in evoking E2 secretion.



View larger version (27K):
[in this window]
[in a new window]
 
Figure 4. Effect of FSH on diameter of type 4 follicles cultured with 1 x 10-7 M DHEA (A), DHEAS (B), T (C), {Delta}4 (D), or DHT (E). Recombinant human FSH (0.1–100 mIU/ml) was added to culture medium on day 0. Data are presented as means ± SEM. Parentheses represent numbers of follicles. *, P < 0.05, **, P < 0.01, ***, P < 0.0001 vs. any of 1 x 10-7 M DHEA, DHEAS, T, {Delta}4, or DHT.

 


View larger version (25K):
[in this window]
[in a new window]
 
Figure 5. Levels of IR-inhibin and E2 section from type 4 follicles cultured with 1 x 10-7 M DHEA, DHEAS, DHT, T, or {Delta}4 together with FSH (10 or 100 mIU/ml). Values are means ± SEM. ND, Not detectable. *, P < 0.05; **, P < 0.01; ***, P < 0.0001 vs. control; {dagger}, P < 0.05, {dagger}{dagger}, P < 0.01, {dagger}{dagger}{dagger}, P < 0.001 vs. FSH 10 mIU/ml; {ddagger}, P < 0.05, {ddagger}{ddagger}, P < 0.01, {ddagger}{ddagger}{ddagger}, P < 0.0001 vs. FSH 100 mIU/ml; aaa, P < 0.0001 vs. DHEA 10-7 M; b, P < 0.05, bb, P < 0.01, bbb, P < 0.0001 vs. DHEAS 10-7 M; cc, P < 0.01, ccc, P < 0.0001 vs. DHT 10-7 M; dd, P < 0.01, ddd, P < 0.0001 vs. T 10-7 M; e, P < 0.05, eee, P < 0.0001 vs. {Delta}4 10-7 M.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Although ovarian androgens have long been implicated as an inhibitor of follicular development (4, 5, 6), evidence suggests that they have stimulatory action. Murray et al. (13) showed using an in vitro whole-follicle culture system that preantral mouse follicles develop faster in the presence of both DHT and a marginal concentration of FSH. Vendola et al. (15) demonstrated in an in vivo study of adult rhesus monkeys that implantation of pellets containing T or DHT significantly increases the number of small growing preantral and antral follicles as well as granulosa and thecal cell proliferation. These findings suggest not only that the effect of androgens on follicular growth depends upon the stage of follicular development but also that androgens exert a direct, stimulatory action on the growth and development of mouse antral follicles. The results of the present study not only support these recent findings but additionally demonstrate that androgens can stimulate the proliferation of type 4 follicles obtained from immature mice. The nature of small preantral follicles from 11-d-old mice differs from that of adult mice (15, 23). Small preantral follicles from adult mice start to grow as the result of FSH stimulation, but those from immature mice are refractory to FSH (23).

Because the response of small preantral follicles from 28-d-old mice is intermediate between immature and adult mice, we speculate that the prepubertal gonadotropin surge is important to the differential responses of immature and adult mice to FSH. The prepubertal gonadotropin surge occurs around 11 d of age and ends by 28 d of age (29). Therefore, an unanswered question is how small preantral follicles of immature mice acquire the initial step in the generation of an FSH response. One putative answer is the presence of intra- and extraovarian growth factors. Because small preantral follicles from 11-d-old mice start to grow as the result of activin A and GH stimulation, we infer that these intra- and extraovarian factors control the initial step of small preantral follicular growth (19). The results of the present study suggest that androgens function in this manner. In particular, adrenal androgens directly stimulate follicular growth, suggesting that the adrenal gland plays an important role in the initiation of prepubertal follicular growth. Despite the fact that the expression and regulation of ARs in neonatal or prepubertal mouse ovaries is not apparent in the adult mouse ovary (30, 31, 32), the results of the present study suggest that ovarian and adrenal androgens play important roles in granulosa cells of type 4 follicles derived from 11-d-old mice acquiring a response to FSH.

It is well known that the various androgens have different levels of affinity for the AR. Nevertheless, as show in Fig. 3Go, the minimal effective dose of androgens was 1 x 10-10 M for both adrenal and ovarian androgens, suggesting that both ovarian and gonadal androgens were equally potent in inducing the growth of type 4 follicles from immature mice. The discrepancy between the different affinity of androgens to their receptor(s) and biological potency can be partly accounted for by the metabolism of androgens during the 4-d culture. It is known that 17ß-hydroxysteroid dehydrogenases and 5{alpha} reductase, which can convert low-activity sex steroids to more potent forms, are expressed in immature mice ovary (33, 34).

Both ovarian and adrenal androgens stimulated proliferation and increased the number of granulosa cells, which was followed by an increase in the size of the follicles. However, the stimulatory effect of androgens on E2 or IR-inhibin secretion from type 4 follicles of immature mice was either relatively weak or absent. We showed that type 4 follicles from 11-d-old mice increase in size and that they secrete more IR-inhibin and E2 upon stimulation by activin A and GH (19). Thus, the action of androgens as seen in the present study is unique. However, Fig. 5Go shows that androgen increased IR-inhibin and E2 production from type 4 follicles stimulated by androgens in the presence of FSH. Such synergistic action of androgen with FSH on follicular growth is already known. Several in vitro studies have demonstrated that androgens in the presence of FSH increase the production of cAMP, progesterone, and aromatase activity in cultured granulosa cells (8, 9, 10, 11, 12). T also significantly increases granulosa cell FSH receptor mRNA at all stages of follicular development in normal cycling rhesus monkeys, whereas FSH increases granulosa AR mRNA levels only in primary follicles (35). The results of the present study demonstrate that synergistic action of androgen with FSH functions even in the type 4 follicles of immature mice, although the exact mechanisms of how such follicles acquire FSH responsiveness is as yet unknown.

Significantly more E2 was released into the culture medium by follicles incubated with FSH and aromatizable androgens than with those incubated with FSH and the nonaromatizable androgen DHT (Fig. 5Go). Because DHT stimulated IR-Inhibin secretion to the same extent as aromatizable androgens did, the decreased effect of DHT on E2 secretion is accounted for by the absence of substrates. Aromatizable androgens may therefore be used as an E precursor by the enzyme cytochrome P450aromatase in the granulosa cells under the influence of FSH (36). P450aromatase mRNA and its activity is detectable in the mouse ovary on the day of birth and thereafter increases in a gonadotropin-dependent manner (22), suggesting that most of the E detected in the culture medium was synthesized de novo by converting aromatizable androgens to E. Moreover, FSH induces P450aromatase mRNA and activity in rat granulosa cells in a dose-, time-, and stage-dependent manner and T and DHT synergistically enhance the levels of P450aromatase mRNA and its activity with FSH (37). Figure 5Go shows that type 4 follicles secreted detectable amounts of E2 as the result of DHT stimulation. Although the present study did not clearly define whether type 4 follicles actually produce androgens, we have shown that type 4 follicles have theca cells and can produce and secrete Es when there is insufficient amounts of substrate (18, 19). Thus, our results suggest, firstly, that androgens in the presence of FSH serve as a precursor of E and enhance E production and, secondly, that type 4 follicles obtained from 11-d-old mice have an extant mechanism of E synthesis.

In conclusion, both adrenal and ovarian androgens directly stimulate FSH-unresponsive type 4 follicles without producing IR-inhibin and E2 and serve to enhance the sensitivity of FSH responsiveness in type 4 follicles from immature mice. In addition, the present results may answer the question as to how type 4 follicles from immature mice can acquire FSH responsiveness, although biochemical mechanisms are yet to be clarified. In this context, the present results suggest that the adrenal gland plays an important role in the initiation of puberty.


    Acknowledgments
 
The authors are grateful to Nippon Kayaku Co. (Tokyo, Japan) for donating the AR antagonist, OH-Flutamide.


    Footnotes
 
Abbreviations: {Delta}4, Androstenedione; BrdU; 5-bromo-2'-deoxyuridine; DHEA, dehydroepiandrosterone; DHEAS, dehydroepiandrosterone sulfate; DHT, dihydrotestosterone; E1, estrone; IR, immunoreactive; rhFSH, recombinant human FSH.

Received January 29, 2001.

Accepted for publication July 18, 2001.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Payne RW, Hellbaum AA, Owens Jr JN 1956 The effect of androgens on the ovaries and uterus of the estrogen treated hypophysectomized immature rats. Endocrinology 59:306–316
  2. Hillier SG, Ross GT 1979 Effects of exogenous testosterone on ovarian weight, follicular morphology and intraovarian progesterone concentration in estrogen-primed hypophysectomized immature female rats. Biol Reprod 20:261–268[Abstract]
  3. Nandedkar TD, Munshi SR 1981 Effect of dihydrotestosterone on follicular development, ovulation and reproductive capacity of mice. J Reprod Fertil 62:21–24[Abstract/Free Full Text]
  4. Jia XC, Kessel B, Welsh Jr TH, Hsueh AJ 1985 Androgen inhibition of follicle-stimulating hormone-stimulated luteinizing hormone receptor formation in cultured rat granulosa cells. Endocrinology 117:13–22[Abstract]
  5. Farookhi R 1985 Effects of aromatizable and nonaromatizable androgen treatments on luteinizing hormone receptors and ovulation induction in immature rats. Biol Reprod 33:363–369[Abstract]
  6. Billig H, Furuta I, Hsueh AJ 1993 Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis. Endocrinology 133:2204–2212[Abstract]
  7. Lucky AW, Schreiber JR, Hillier SG, Schulman JD, Ross GT 1977 Progesterone production by cultured preantral rat granulosa cells: stimulation by androgens. Endocrinology 100:128–133[Abstract]
  8. Armstrong DT, Dorrington JH 1976 Androgens augment FSH-induced progesterone secretion by cultured rat granulosa cells. Endocrinology 99:1411–1414[Abstract]
  9. Nimrod A, Lindner HR 1976 A synergistic effect of androgen on the stimulation of progesterone secretion by FSH in cultured rat granulosa cells. Mol Cell Endocrinol 5:315–320[CrossRef][Medline]
  10. Goff AK, Leung PC, Armstrong DT 1979 Stimulatory action of follicle-stimulating hormone and androgens on the responsiveness of rat granulosa cells to gonadotropins in vitro. Endocrinology 104:1124–1129[Medline]
  11. Daniel SA, Armstrong DT 1980 Enhancement of follicle-stimulating hormone-induced aromatase activity by androgens in cultured rat granulosa cells. Endocrinology 107:1027–1033[Medline]
  12. Hillier SG, De Zwart FA 1981 Evidence that granulosa cell aromatase induction/activation by follicle-stimulating hormone is an androgen receptor-regulated process in vitro. Endocrinology 109:1303–1305[Abstract]
  13. Murray AA, Gosden RG, Allison V, Spears N 1998 Effect of androgens on the development of mouse follicles growing in vitro. J Reprod Fertil 113:27–33[Abstract/Free Full Text]
  14. Spears N, Murray AA, Allison V, Boland NI, Gosden RG 1998 Role of gonadotrophins and ovarian steroids in the development of mouse follicles in vitro. J Reprod Fertil 113:19–26[Abstract/Free Full Text]
  15. Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA 1998 Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 101:2622–2629[Medline]
  16. Styne DM, Grumbach MM 1991 Disorders of puberty in the male and female. In: Yen SSC, Jaffe RB, eds. Reproductive endocrinology, ed 3. Philadelphia: WB Saunders Co.; 511–554
  17. Kumar TR, Wang Y, Lu N, Matzuk MM 1997 Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat Genet 15:201–204[CrossRef][Medline]
  18. Liu X, Andoh K, Abe Y, et al. 1999 A comparative study on transforming growth factor-ß and activin A for preantral follicles from adult, immature, and diethylstilbestrol-primed immature mice. Endocrinology 140:2480–2485[Abstract/Free Full Text]
  19. Liu X, Andoh K, Yokota H, et al. 1998 Effects of growth hormone, activin, and follistatin on the development of preantral follicle from immature female mice. Endocrinology 139:2342–2347[Abstract/Free Full Text]
  20. Ohno S, Christian L, Attardi B 1973 Role of testosterone in normal female function. Nature 243:119–120
  21. Lyon MF, Glenster PH 1980 Reduced reproductive performance in androgen-resistant Tfm/Tfm female mice. Proc R Soc Lond B Biol Sci 208:1–12[Medline]
  22. Gray SA, Mannan MA, O’Shaughnessy PJ 1995 Development of cytochrome P450 aromatase mRNA levels and enzyme activity in ovaries of normal and hypogonadal (hpg) mice. J Mol Endocrinol 14:295–301[Abstract/Free Full Text]
  23. Yokota H, Yamada K, Liu X, et al. 1997 Paradoxical action of activin A on folliculogenesis in immature and adult mice. Endocrinology 138:4572–4576[Abstract/Free Full Text]
  24. Pedersen T, Peters H 1968 Proposal for a classification of oocytes and follicles in the mouse ovary. J Reprod Fertil 17:555–557[Abstract/Free Full Text]
  25. Hamada T, Watanabe G, Kokubo T, et al. 1989 Radioimmunoassay of inhibin in various mammals. J Endocrinol 122:697–704[Abstract/Free Full Text]
  26. Crowley Jr WF, Beitins IZ, Vale W, et al. 1980 The biologic activity of a potent analogue of gonadotropin-releasing hormone in normal and hypogonadotropic men. N Engl J Med 302:1052–1057[Abstract]
  27. Takahashi Y, Hasegawa Y, Yazaki C, Igarashi M 1985 Direct immunoassay of progesterone in rat serum. Endocrinol Jpn 32:661–672[Medline]
  28. Rodriguz J, Deinhardt F 1960 Preparation of a semipermanent mounting medium for fluorescence antibody studies. Virology 12:316–317
  29. Stiff ME, Bronson FH, Stetson MH 1974 Plasma gonadotropins in prenatal and prepubertal female mice: disorganization of pubertal cycles in the absence of a male. Endocrinology 94:492–496[Medline]
  30. Weil SJ, Vendola K, Zhou J, et al. 1998 Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. J Clin Endocrinol Metab 83:2479–2485[Abstract/Free Full Text]
  31. Tetsuka M, Hillier SG 1996 Androgen receptor gene expression in rat granulosa cells: the role of follicle-stimulating hormone and steroid hormones. Endocrinology 137:4392–4397[Abstract]
  32. Garrett WM, Guthrie HD 1996 Expression of androgen receptors and steroidogenic enzymes in relation to follicular growth and atresia following ovulation in pigs. Biol Reprod 55:949–955[Abstract]
  33. Aono T, Kitamura S, Fukuda S, Matsumoto K 1981 Localization of 4-ene-5{alpha}-reductase, 17ß-ol-dehydrogenase and aromatase in immature rat ovary. J Steroid Biochem 14:1369–1377[CrossRef][Medline]
  34. Akinola LA, Poutanen M, Vihko R, Vihko P 1997 Expression of 17ß-hydroxysteroid dehydrogenase type 1 and type 2, P450 aromatase, and 20{alpha}-hydroxysteroid dehydrogenase enzymes in immature, mature, and pregnant rats. Endocrinology 138:2886–2892[Abstract/Free Full Text]
  35. Weil S, Vendola K, Zhou J, Bondy CA 1999 Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 84:2951–2956[Abstract/Free Full Text]
  36. Dorrington JH, Moon YS, Armstrong DT 1975 Estradiol-17ß biosynthesis in cultured granulosa cells from hypophysectomized immature rats; stimulation by follicle-stimulating hormone. Endocrinology 97:1328–1331[Abstract]
  37. Fitzpatrick SL, Richards JS 1991 Regulation of cytochrome P450 aromatase messenger ribonucleic acid and activity by steroids and gonadotropins in rat granulosa cells. Endocrinology 129:1452–1462[Abstract]



This article has been cited by other articles:


Home page
J EndocrinolHome page
T. da Silva Faria, F. de Bittencourt Brasil, F. J B Sampaio, and C. da Fonte Ramos
Maternal malnutrition during lactation alters the folliculogenesis and gonadotropins and estrogen isoforms ovarian receptors in the offspring at puberty
J. Endocrinol., September 1, 2008; 198(3): 625 - 634.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K.A. Walters, C.M. Allan, and D.J. Handelsman
Androgen Actions and the Ovary
Biol Reprod, March 1, 2008; 78(3): 380 - 389.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Rice, K. Ojha, S. Whitehead, and H. Mason
Stage-Specific Expression of Androgen Receptor, Follicle-Stimulating Hormone Receptor, and Anti-Mullerian Hormone Type II Receptor in Single, Isolated, Human Preantral Follicles: Relevance to Polycystic Ovaries
J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1034 - 1040.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M.Y. Yang and J.E. Fortune
Testosterone Stimulates the Primary to Secondary Follicle Transition in Bovine Follicles In Vitro
Biol Reprod, December 1, 2006; 75(6): 924 - 932.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. Orisaka, K. Tajima, T. Mizutani, K. Miyamoto, B. K. Tsang, S. Fukuda, Y. Yoshida, and F. Kotsuji
Granulosa Cells Promote Differentiation of Cortical Stromal Cells into Theca Cells in the Bovine Ovary
Biol Reprod, November 1, 2006; 75(5): 734 - 740.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
W. Luo and M. C. Wiltbank
Distinct Regulation by Steroids of Messenger RNAs for FSHR and CYP19A1 in Bovine Granulosa Cells
Biol Reprod, August 1, 2006; 75(2): 217 - 225.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y.-C. Hu, P.-H. Wang, S. Yeh, R.-S. Wang, C. Xie, Q. Xu, X. Zhou, H.-T. Chao, M.-Y. Tsai, and C. Chang
Subfertility and defective folliculogenesis in female mice lacking androgen receptor
PNAS, August 3, 2004; 101(31): 11209 - 11214.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
T.E. Hickey, D.L. Marrocco, R.B. Gilchrist, R.J. Norman, and D.T. Armstrong
Interactions Between Androgen and Growth Factors in Granulosa Cell Subtypes of Porcine Antral Follicles
Biol Reprod, July 1, 2004; 71(1): 45 - 52.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, H.
Right arrow Articles by Mizunuma, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, H.
Right arrow Articles by Mizunuma, H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals